Have your own idea? Try our Stock Screener
UPDATED Jan 22, 2025
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SIGA | US$6.39 | 0.6% | 26.3% | US$451.3m | n/a | PE5.3x | S7.5% | 9.4% | ||
OGN | US$15.87 | 0.9% | -3.3% | US$4.1b | US$21.25 | PE3.1x | E-8.3% | 7.1% | ||
PFE | US$26.01 | -0.8% | -8.2% | US$151.0b | US$31.18 | PE34.5x | E8.5% | 6.6% | ||
PRGO | US$24.05 | 2.3% | -27.1% | US$3.3b | US$34.20 | PB0.7x | E64.4% | 4.6% | ||
BMY | US$57.09 | 2.1% | 13.6% | US$115.7b | US$61.01 | PS2.4x | E39.3% | 4.3% | ||
VTRS | US$11.14 | -2.2% | -4.9% | US$13.5b | US$13.45 | PB0.7x | E51.6% | 4.3% | ||
ABBV | US$169.20 | -1.3% | 3.0% | US$305.0b | US$199.97 | PE58.8x | E22.7% | 3.9% | ||
AMGN | US$273.44 | 1.7% | -10.5% | US$147.7b | US$317.24 | PE34.7x | E15.8% | 3.5% | ||
JNJ | US$145.27 | 0.2% | -8.6% | US$356.7b | US$171.29 | PE23.7x | E10.5% | 3.4% | ||
MRK | US$95.68 | -4.4% | -19.5% | US$243.5b | US$125.13 | PE19.9x | E12.0% | 3.4% | ||
GILD | US$93.04 | 0.7% | 17.0% | US$115.9b | US$99.96 | PE920.3x | E31.1% | 3.3% | ||
RPRX | US$30.08 | -2.1% | 3.4% | US$17.9b | US$40.66 | PE11.7x | E2.0% | 2.8% | ||
QGEN | US$47.25 | 4.4% | 4.5% | US$10.6b | US$51.14 | PE113x | E34.4% | 2.7% | ||
ILMN | US$140.36 | 3.1% | -0.5% | US$22.4b | US$161.92 | PS5.1x | E54.8% | 2.2% | ||
PAHC | US$21.76 | 4.3% | 98.0% | US$871.2m | US$19.40 | PE50.6x | E60.0% | 2.2% | ||
ZTS | US$166.63 | -0.3% | -10.4% | US$75.6b | US$210.66 | PE30.9x | E10.0% | 1.2% | ||
LLY | US$753.98 | 1.0% | 19.0% | US$668.4b | US$978.39 | PE81.1x | E24.8% | 0.8% | ||
A | US$152.60 | 7.3% | 17.6% | US$43.6b | US$150.13 | PE33.8x | E8.2% | 0.7% | ||
DHR | US$244.18 | 2.6% | 6.8% | US$176.3b | US$284.39 | PE44.8x | E13.1% | 0.4% | ||
MLAB | US$144.85 | 7.2% | 55.4% | US$796.5m | US$133.33 | PS3.4x | E124.7% | 0.4% | ||
TECH | US$78.71 | 4.8% | 10.8% | US$12.5b | US$85.26 | PE83x | E21.1% | 0.4% | ||
BRKR | US$60.12 | 4.5% | -16.0% | US$9.1b | US$73.80 | PE29.9x | E15.8% | 0.3% | ||
TMO | US$574.59 | 4.2% | 6.4% | US$219.2b | US$645.22 | PE35.8x | E11.3% | 0.3% | ||
STVN | US$21.52 | -2.8% | -29.1% | US$6.1b | US$26.38 | PE49.2x | E19.7% | 0.3% |